Related Experiment Video
Updated: Jul 8, 2026
08:39
A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
Broken pump or leaky filter? Renal dysfunction in heart failure a contemporary review
Colin J Petrie1, Partick B Mark, Robin A P Weir
1Department of Cardiology, Western Infirmary, Glasgow, United Kingdom. colinjamespetrie@yahoo.co.uk
International Journal of Cardiology
|January 15, 2008
Summary
Kidney dysfunction is common in chronic heart failure (CHF) patients and predicts cardiovascular mortality. Even mild renal impairment impacts outcomes across various heart failure types, highlighting its significance.
Area of Science:
- Cardiology
- Nephrology
- Clinical Medicine
Background:
- Renal dysfunction is a frequent, progressive complication of chronic heart failure (CHF).
- It is a strong predictor of cardiovascular mortality and is linked to cardiovascular disease early on.
- Shared risk factors exist between cardiovascular and renal disease, but prognostic implications extend beyond generalized atherosclerosis.
Purpose of the Study:
- To investigate the prognostic significance of renal dysfunction in chronic heart failure.
- To explore the impact of renal impairment on outcomes in diverse heart failure populations.
- To highlight the underrepresentation of these patients in clinical trials.
Main Methods:
- Analysis of patient data from clinical studies focusing on heart failure.
- Assessment of renal function markers in relation to cardiovascular outcomes.
- Stratification of patients based on heart failure type and renal function status.
Main Results:
- Renal dysfunction is a significant predictor of adverse outcomes in CHF patients.
- The negative impact of renal impairment on prognosis is evident even in mild cases.
- This association holds true across different heart failure etiologies, including idiopathic dilated cardiomyopathy and coronary artery disease, and in heart failure with preserved systolic function.
- Renal dysfunction often limits intensive treatment interventions.
Conclusions:
- Renal dysfunction plays a critical role in the progression and outcomes of chronic heart failure.
- Mild renal impairment carries significant prognostic weight in a broad spectrum of heart failure patients.
- Addressing renal dysfunction is crucial for improving outcomes in heart failure, yet these patients are often excluded from clinical trials, necessitating better representation.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.